FDA Inspection 1144691 — Etienne M. H. Sokal, MD, PhD.
The FDA completed an inspection of Etienne M. H. Sokal, MD, PhD. on June 4, 2021 in Brussels. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 4, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Brussels (Belgium)
Additional Details
Clinical Investigator (CI)